Table 2. Mode of Detection and Number of HCCs during 2-Year Clinical Follow-Up.
| Number of HCCs | Initial Dynamic CT | First Detected on Initial CBCT-HA and Treated with TACE | Detected during 2-Year Clinical Follow-Up | Total | |
|---|---|---|---|---|---|
| At 1-Year | At 2-Year | ||||
| Number of HCCs preexisting on initial CBCT-HA | 149* | 74† | 74‡(interval growth of preexisting lesion on initial CBCT-HA) | 297 | |
| 46 | 28 | ||||
| Number of de novo HCCs | - | - | 108 | 108 | |
| 28 | 80 | ||||
*Group I HCC, †Group II HCC, ‡Group III HCC. HCC = hepatocellular carcinoma, TACE = transcatheter arterial chemoembolization